Hanson R F, Staples A B, Williams G C
J Lipid Res. 1979 May;20(4):489-93.
Side chain oxidation and cleavage of precursors in cholic acid synthesis is thought to involve initial hydroxylation at either position 25 or 26 of the side chain. Therefore, the conversion of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 26-tetrol and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol into cholic acid was studied in normal subjects after single intravenous injections of these labeled alcohols. Eighty-six percent and 82% of 5 beta-cholestane, 3 alpha, 7 alpha, 12 alpha, 26-tetrol was converted into cholic acid in two subjects, respectively. However, only 14 and 16% of the injected 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol was converted into cholic acid in two subjects, respectively. Thus, this study indicates that 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol is an inefficient substrate for cholic acid biosynthesis in man and that the major route of cholic acid synthesis probably involves the 26-hydroxylated intermediate.
胆酸合成过程中前体的侧链氧化和裂解被认为涉及侧链25位或26位的初始羟基化。因此,在正常受试者单次静脉注射这些标记醇后,研究了5β-胆甾烷-3α,7α,12α,26-四醇和5β-胆甾烷-3α,7α,12α,25-四醇向胆酸的转化。在两名受试者中,5β-胆甾烷-3α,7α,12α,26-四醇分别有86%和82%转化为胆酸。然而,在两名受试者中,注射的5β-胆甾烷-3α,7α,12α,25-四醇分别仅有14%和16%转化为胆酸。因此,本研究表明5β-胆甾烷-3α,7α,12α,25-四醇是人胆酸生物合成的低效底物,胆酸合成的主要途径可能涉及26-羟基化中间体。